Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-015833

CFO & Executive Vice President sold 954 shares at an average $65.71 ($62,686)

  • CFO & Executive Vice President acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dier Mardi CFO & Executive Vice President 2022-03-01 Sale −534 $66.62 $35,575 38,228 D
Dier Mardi CFO & Executive Vice President 2022-03-01 Grant or award +14,000 52,228 D
Dier Mardi CFO & Executive Vice President 2022-03-03 Sale −420 $64.55 $27,111 51,808 D
Derivatives
Dier Mardi CFO & Executive Vice President 2022-03-01 Grant or award · Stock Option (Right to Buy) +24,900 24,900 D
Open-market sales · 954 sh · avg $65.71 · $62,686
Loading xslF345X03/doc4.xml…